Search This Site:

Clinical Guidelines & Pathways

Osteoporosis Guideline

Guideline added to website on: 08/06/2020
Last modified on: 10/12/2020
CCG: |
Category: |
Tags: bisphosphonate, denosumab, Osteoporosis

Please note this guideline is in the process of being updated to incorporate the MHRA advice regarding NOT stopping or delaying ongoing denosumab treatment WITHOUT a specialist review . (See below the red coloured 'view guideline PDF' box for a link to the full MHRA drug safety update.)

(The previous osteoporosis guidelines (April 2019) are attached for reference only purposes)
Scroll to Top